Orange Book product · Brand (NDA)
EPIDIOLEX
CANNABIDIOL
At a glance
Sep 28, 2018
Approved
Brand (NDA)
Application
Not listed
TE code
57
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 28, 2018
7 yr 10 mo ago
Today
Exclusivity ends · M-270
New use / labeling-change exclusivity (3 years)
Oct 20, 2026
in 4 mo
Exclusivity ends · ODE-326
Orphan-drug exclusivity (7 years)
Jul 31, 2027
in 1 yr 2 mo
Exclusivity ends · ODE-332
Orphan-drug exclusivity (7 years)
Jul 31, 2027
in 1 yr 2 mo
Patent 10092525 expires
Listed method-of-use patent (U-2427) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 10111840 expires
Listed method-of-use patent (U-2443) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 10111840 expires
Listed method-of-use patent (U-2442) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 10137095 expires
Listed method-of-use patent (U-2454) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 10137095 expires
Listed method-of-use patent (U-2455) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 10603288 expires
Listed method-of-use patent (U-2780) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 10603288 expires
Listed method-of-use patent (U-2781) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 10603288 expires
Listed method-of-use patent (U-2782) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 10603288 expires
Listed method-of-use patent (U-2783) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 10709671 expires
Listed method-of-use patent (U-2862) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 10709673 expires
Listed drug product patent expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 10709674 expires
Listed method-of-use patent (U-2781) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 10709674 expires
Listed method-of-use patent (U-2780) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 10849860 expires
Listed method-of-use patent (U-2427) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 10849860 expires
Listed method-of-use patent (U-2454) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 10966939 expires
Listed drug product patent expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 10966939 expires
Listed drug product patent expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 11154516 expires
Listed method-of-use patent (U-3235) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 11154516 expires
Listed method-of-use patent (U-3236) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 11311498 expires
Listed method-of-use patent (U-3375) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 11311498 expires
Listed method-of-use patent (U-3376) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 11357741 expires
Listed method-of-use patent (U-2862) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 11446258 expires
Listed method-of-use patent (U-2780) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 11446258 expires
Listed method-of-use patent (U-2781) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 11446258 expires
Listed method-of-use patent (U-3071) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 11633369 expires
Listed drug product patent expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 11633369 expires
Listed drug product patent expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 11633369 expires
Listed drug product patent expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 11701330 expires
Listed method-of-use patent (U-2780) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 11701330 expires
Listed method-of-use patent (U-2781) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 11766411 expires
Listed method-of-use patent (U-2781) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 11963937 expires
Listed method-of-use patent (U-2780) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 11963937 expires
Listed method-of-use patent (U-2781) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 12064399 expires
Listed method-of-use patent (U-3988) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 12064399 expires
Listed method-of-use patent (U-3989) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 9949937 expires
Listed method-of-use patent (U-2421) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 9956183 expires
Listed method-of-use patent (U-2422) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 9956183 expires
Listed method-of-use patent (U-2423) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 9956184 expires
Listed method-of-use patent (U-2424) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 9956185 expires
Listed method-of-use patent (U-2425) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 9956186 expires
Listed method-of-use patent (U-2426) expiration.
Jun 17, 2035
in 9 yr 2 mo
Patent 10918608 expires
Listed method-of-use patent (U-3072) expiration.
Oct 13, 2035
in 9 yr 5 mo
Patent 10918608 expires
Listed method-of-use patent (U-3071) expiration.
Oct 13, 2035
in 9 yr 5 mo
Patent 10918608 expires
Listed method-of-use patent (U-3073) expiration.
Oct 13, 2035
in 9 yr 5 mo
Patent 11065209 expires
Listed method-of-use patent (U-3071) expiration.
Oct 13, 2035
in 9 yr 5 mo
Patent 11096905 expires
Listed drug substance patent expiration.
Oct 13, 2035
in 9 yr 5 mo
Patent 11096905 expires
Listed drug substance patent expiration.
Oct 13, 2035
in 9 yr 5 mo
Patent 11400055 expires
Listed method-of-use patent (U-3071) expiration.
Oct 13, 2035
in 9 yr 5 mo
Patent 11207292 expires
Listed drug substance patent expiration.
Apr 26, 2039
in 13 yr
Patent 11207292 expires
Listed drug substance patent expiration.
Apr 26, 2039
in 13 yr
Patent 11207292 expires
Listed drug substance patent expiration.
Apr 26, 2039
in 13 yr
Patent 11865102 expires
Listed drug substance patent expiration.
Apr 26, 2039
in 13 yr
Patent 11865102 expires
Listed drug substance patent expiration.
Apr 26, 2039
in 13 yr
Patent 11865102 expires
Listed drug substance patent expiration.
Apr 26, 2039
in 13 yr
Patent 11160795 expires
Listed method-of-use patent (U-3233) expiration.
Mar 01, 2041
in 14 yr 11 mo
Patent 11406623 expires
Listed method-of-use patent (U-3233) expiration.
Mar 01, 2041
in 14 yr 11 mo
Patent 12102619 expires
Listed method-of-use patent (U-3233) expiration.
Mar 01, 2041
in 14 yr 11 mo
Pharmaceutical detail
Active ingredient
CANNABIDIOL
Strength
100MG/ML
Dosage form
SOLUTION
Route
ORAL
TE code
Not listed
Application
NDA 210365
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Marketing exclusivity (3)
- M-270New use / labeling-change exclusivity (3 years)
Oct 20, 2026
in 4 mo
- ODE-326Orphan-drug exclusivity (7 years)
Jul 31, 2027
in 1 yr 2 mo
- ODE-332Orphan-drug exclusivity (7 years)
Jul 31, 2027
in 1 yr 2 mo
Listed patents (57)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10092525 | Jun 17, 2035 | in 9 yr 2 mo | U-2427 |
| 10111840 | Jun 17, 2035 | in 9 yr 2 mo | U-2443 |
| 10111840 | Jun 17, 2035 | in 9 yr 2 mo | U-2442 |
| 10137095 | Jun 17, 2035 | in 9 yr 2 mo | U-2454 |
| 10137095 | Jun 17, 2035 | in 9 yr 2 mo | U-2455 |
| 10603288 | Jun 17, 2035 | in 9 yr 2 mo | U-2780 |
| 10603288 | Jun 17, 2035 | in 9 yr 2 mo | U-2781 |
| 10603288 | Jun 17, 2035 | in 9 yr 2 mo | U-2782 |
| 10603288 | Jun 17, 2035 | in 9 yr 2 mo | U-2783 |
| 10709671 | Jun 17, 2035 | in 9 yr 2 mo | U-2862 |
| 10709673 | Jun 17, 2035 | in 9 yr 2 mo | Product |
| 10709674 | Jun 17, 2035 | in 9 yr 2 mo | U-2781 |
| 10709674 | Jun 17, 2035 | in 9 yr 2 mo | U-2780 |
| 10849860 | Jun 17, 2035 | in 9 yr 2 mo | U-2427 |
| 10849860 | Jun 17, 2035 | in 9 yr 2 mo | U-2454 |
| 10966939 | Jun 17, 2035 | in 9 yr 2 mo | ProductU-2780 |
| 10966939 | Jun 17, 2035 | in 9 yr 2 mo | ProductU-2781 |
| 11154516 | Jun 17, 2035 | in 9 yr 2 mo | U-3235 |
| 11154516 | Jun 17, 2035 | in 9 yr 2 mo | U-3236 |
| 11311498 | Jun 17, 2035 | in 9 yr 2 mo | U-3375 |
| 11311498 | Jun 17, 2035 | in 9 yr 2 mo | U-3376 |
| 11357741 | Jun 17, 2035 | in 9 yr 2 mo | U-2862 |
| 11446258 | Jun 17, 2035 | in 9 yr 2 mo | U-2780 |
| 11446258 | Jun 17, 2035 | in 9 yr 2 mo | U-2781 |
| 11446258 | Jun 17, 2035 | in 9 yr 2 mo | U-3071 |
| 11633369 | Jun 17, 2035 | in 9 yr 2 mo | ProductU-2780 |
| 11633369 | Jun 17, 2035 | in 9 yr 2 mo | ProductU-3071 |
| 11633369 | Jun 17, 2035 | in 9 yr 2 mo | ProductU-2781 |
| 11701330 | Jun 17, 2035 | in 9 yr 2 mo | U-2780 |
| 11701330 | Jun 17, 2035 | in 9 yr 2 mo | U-2781 |
| 11766411 | Jun 17, 2035 | in 9 yr 2 mo | U-2781 |
| 11963937 | Jun 17, 2035 | in 9 yr 2 mo | U-2780 |
| 11963937 | Jun 17, 2035 | in 9 yr 2 mo | U-2781 |
| 12064399 | Jun 17, 2035 | in 9 yr 2 mo | U-3988 |
| 12064399 | Jun 17, 2035 | in 9 yr 2 mo | U-3989 |
| 9949937 | Jun 17, 2035 | in 9 yr 2 mo | U-2421 |
| 9956183 | Jun 17, 2035 | in 9 yr 2 mo | U-2422 |
| 9956183 | Jun 17, 2035 | in 9 yr 2 mo | U-2423 |
| 9956184 | Jun 17, 2035 | in 9 yr 2 mo | U-2424 |
| 9956185 | Jun 17, 2035 | in 9 yr 2 mo | U-2425 |
| 9956186 | Jun 17, 2035 | in 9 yr 2 mo | U-2426 |
| 10918608 | Oct 13, 2035 | in 9 yr 5 mo | U-3072 |
| 10918608 | Oct 13, 2035 | in 9 yr 5 mo | U-3071 |
| 10918608 | Oct 13, 2035 | in 9 yr 5 mo | U-3073 |
| 11065209 | Oct 13, 2035 | in 9 yr 5 mo | U-3071 |
| 11096905 | Oct 13, 2035 | in 9 yr 5 mo | SubstanceProductU-2780 |
| 11096905 | Oct 13, 2035 | in 9 yr 5 mo | SubstanceProductU-2781 |
| 11400055 | Oct 13, 2035 | in 9 yr 5 mo | U-3071 |
| 11207292 | Apr 26, 2039 | in 13 yr | SubstanceU-3235 |
| 11207292 | Apr 26, 2039 | in 13 yr | SubstanceU-3277 |
| 11207292 | Apr 26, 2039 | in 13 yr | SubstanceU-3236 |
| 11865102 | Apr 26, 2039 | in 13 yr | SubstanceProductU-2781 |
| 11865102 | Apr 26, 2039 | in 13 yr | SubstanceProductU-3236 |
| 11865102 | Apr 26, 2039 | in 13 yr | SubstanceProductU-3277 |
| 11160795 | Mar 01, 2041 | in 14 yr 11 mo | U-3233 |
| 11406623 | Mar 01, 2041 | in 14 yr 11 mo | U-3233 |
| 12102619 | Mar 01, 2041 | in 14 yr 11 mo | U-3233 |

